Paediatric asthma
| dc.contributor.author | Green, Robin J. | |
| dc.contributor.author | Outhoff, Kim | |
| dc.contributor.email | kim.outhoff@up.ac.za | en_US |
| dc.date.accessioned | 2023-02-08T12:21:20Z | |
| dc.date.available | 2023-02-08T12:21:20Z | |
| dc.date.issued | 2022 | |
| dc.description.abstract | Childhood asthma has been with us for many years, and prevalence has been increasing. Asthma is the fifth most common killer in our country, and although it may not kill as many people as infectious diseases, the quality of life of an asthmatic may be seriously impaired, leaving a child or adult with compromised lung health that never goes away. The diagnosis of asthma, which is characterised by variable expiratory airflow limitation, is primarily based on recurrent cough and wheeze. Asthma management should be personalised, and longterm asthma management involves assessing, adjusting and reviewing treatment response. Medication should be titrated up or down for individual patient needs. | en_US |
| dc.description.department | Pharmacology | en_US |
| dc.description.librarian | am2023 | en_US |
| dc.description.uri | http://www.sapj.co.za/index.php/sapj | en_US |
| dc.identifier.citation | Green, R. & Outhoff, K. 2022, 'Paediatric asthma', SA Pharmaceutical Journal, vol. 89, no. 4, pp. 12-14. | en_US |
| dc.identifier.issn | 2221-5875 (print) | |
| dc.identifier.issn | 2220-1017 (online) | |
| dc.identifier.uri | https://repository.up.ac.za/handle/2263/89345 | |
| dc.language.iso | en | en_US |
| dc.publisher | Medpharm Publications | en_US |
| dc.rights | © Medpharm. This article is licensed under a This article is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.5 South Africa License. | en_US |
| dc.subject | Paediatric asthma | en_US |
| dc.subject | Inhaled corticosteroids | en_US |
| dc.subject | Long-acting beta2-agonist (LABA) | en_US |
| dc.subject | Short-acting beta2-agonist (SABA) | en_US |
| dc.title | Paediatric asthma | en_US |
| dc.type | Article | en_US |